Sensydia: Non-Invasive Cardiac Diagnostic Company Secures $3 Million NIH Grant

/

Sensydia – a non-invasive cardiac diagnostic company – announced recently that it was awarded a Fast-Track Small Business grant from the National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health (NIH). This award provides Sensydia with non-dilutive funding for the development and clinical testing of the machine learning algorithms for the Cardiac Performance System (CPS), which was designed to enable earlier detection and therapy guidance for patients with heart failure and pulmonary hypertension.

The Phase I of the grant proposal is budgeted for approximately $600,000 and Phase II for $2.4M, following the successful completion of Phase I milestones. And this NIH award marks a significant milestone for Sensydia, a company committed to developing AI-based solutions for the diagnosis and management of cardiopulmonary diseases. Sensydia recently raised $8M in venture funding.

Click here for more…..

Project Canary CEO: ‘Cut the Crap’ on Energy Transition, Fossil Fuels

/

I'm Jordan Blum, editorial director with Hart Energy here at CERAWeek by S&P Global, and I'm talking to Chris Romer, CEO of Project Canary.

Jordan Blum: So much of the focus with the energy transition is on renewable energy, but just as important is making oil and gas as clean as possible. Can you talk about just how Project Canary comes into play?

Chris Romer: Well, let's define this energy transition because this is my third CERAWeek and this is really exciting. Look, the energy transition is about energy abundance. We need to cut the crap: the way to get to energy transition is less? No, we need affordable, clean American energy going all over the world. And this is exciting because this CERAWeek has proven to me the energy transition has really started. And Project Canary is a measurement company, we do measurement for MRV [measurement, reporting and verification] to help with methane and with carbon sequestration. We are ground zero for this conversation because we are entering into an era of clean, abundant energy. Renewable is going to play a role, but we're also going to get to net-zero fossil fuels, and we're going to get there very quickly with measurement, and we're really excited about the energy here. I get it, $800 billion worth of tax credits can get a lot of capitalists excited and we are a capitalist.

Click here for more…..

HData and Southern Company Announce AI Pilot Program to Revolutionize Utility Regulatory Data Management

/

BIRMINGHAM, Ala., June 6, 2023 /PRNewswire/ -- HData, an innovative RegTech company and TechStars graduate, and Southern Company, a leading energy provider, today announced the launch of a pilot program to HData's unique artificial intelligence-based platform for managing regulatory data at electric and gas utilities. The pilot will explore the benefits of Regulatory AI in key subject areas that support departments such as Regulatory Accounting, Accounting, Finance, and Treasury.

Join HData and Southern Company here for a live conversation about Regulatory AI today, June 6, at 10 a.m. CDT and sign up for one week of free access to Regulatory AI here.

Southern Company subsidiaries Alabama Power, Georgia Power, Mississippi Power, and Southern Company Gas will be the first electric and gas utilities to utilize this revolutionary AI-based software, which will enable these companies to monitor compliance and risks across jurisdictions with confidence and ease.

Click here for more…..

Sensydia Secures $3M NIH Grant to Advance AI-Based Cardiac Assessment Platform

/

NIH STTR Fast-Track grant helps propel Sensydia’s non-invasive CPS platform building on recent funding round

LOS ANGELES, June 05, 2023--(BUSINESS WIRE)--Non-invasive cardiac diagnostic company Sensydia announced today that it was awarded a Fast-Track Small Business grant from the National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health (NIH).

The award provides Sensydia with non-dilutive funding for the development and clinical testing of the machine learning algorithms for the Cardiac Performance System (CPS), designed to enable earlier detection and therapy guidance for patients with heart failure and pulmonary hypertension.

"We are honored to be a recipient of this competitive award from the NIH/NHLBI and look forward to unlocking the capabilities of AI-based cardiac assessment to provide personalized care to patients suffering from heart disease," said Aman Mahajan, MD, Sensydia Chief Medical Officer.

Click here for more…..